+4,303.9%
REGN vs GSK
+963.9%
+3,340.0%
-91.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -0.1% | -0.1% | -0.1% |
| 7D | -3.5% | -5.3% | +1.8% | -1.3% |
| 30D | +14.4% | -3.7% | +18.1% | +16.0% |
| 3M | +11.5% | -7.3% | +18.7% | +14.8% |
| 6M | +42.0% | -4.2% | +46.2% | +44.0% |
| YTD | +19.9% | +0.9% | +19.0% | +18.6% |
| 1Y | +25.5% | +7.3% | +18.3% | +21.1% |
| 3Y | +16.1% | +52.7% | -36.7% | -5.4% |
| 5Y | +42.5% | +40.1% | +2.4% | +18.4% |
| 10Y | +134.1% | +98.7% | +35.3% | +65.0% |
| All | +4,303.9% | +963.9% | +3,340.0% | +1,333.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling